SCHEMBL17875864

SCHEMBL17875864

c1cncc(-c2cc(-c3cccnc3)cc(-c3ccc4c(c3)COCc3ccc(-c5ccc6c(c5)oc5ccccc56)cc3-4)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 12/20 0.41
CYP11B2 P19099 12/20 0.41
CYP1A2 P05177 5/20 0.40
TDP2 O95551 2/20 0.40
CYP19A1 P11511 4/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
PGR P06401 1/20 0.36
CYP17A1 P05093 2/20 0.35
PDK2 Q15119 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875835 1.00 CYP11B1 (0.41) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17875898 0.96 CYP11B1 (0.41) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17875865 0.94 CYP11B1 (0.41) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17875849 0.94 CYP11B1 (0.41) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17875902 0.89 CYP11B1 (0.41) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17875866 0.89 CYP11B1 (0.39) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17875851 0.89 CYP11B1 (0.39) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17875830 0.88 ALOX5 (0.42) CYP11B1CYP11B2CYP1A2TDP2CYP3A4
SCHEMBL17875863 0.88 ALOX5 (0.42) CYP11B1CYP11B2CYP1A2TDP2CYP3A4
SCHEMBL17875844 0.88 NPC1 (0.38) TDP2KDM4ENPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP1A2 757/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP1A2 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.